310 related articles for article (PubMed ID: 33332370)
1. Geographical distribution of Enterobacterales with a carbapenemase IMP-6 phenotype and its association with antimicrobial use: An analysis using comprehensive national surveillance data on antimicrobial resistance.
Hirabayashi A; Yahara K; Kajihara T; Sugai M; Shibayama K
PLoS One; 2020; 15(12):e0243630. PubMed ID: 33332370
[TBL] [Abstract][Full Text] [Related]
2. The plasmid-encoded transcription factor ArdK contributes to the repression of the IMP-6 metallo-β-lactamase gene blaIMP-6, leading to a carbapenem-susceptible phenotype in the blaIMP-6-positive Escherichia coli strain A56-1S.
Segawa T; Sekizuka T; Suzuki S; Shibayama K; Matsui M; Kuroda M
PLoS One; 2018; 13(12):e0208976. PubMed ID: 30533034
[TBL] [Abstract][Full Text] [Related]
3. Molecular and Epidemiological Characteristics of Carbapenemase-Producing Klebsiella pneumoniae Clinical Isolates in Japan.
Yonekawa S; Mizuno T; Nakano R; Nakano A; Suzuki Y; Asada T; Ishii A; Kakuta N; Tsubaki K; Mizuno S; Ogawa M; Yano H; Kasahara K; Mikasa K
mSphere; 2020 Oct; 5(5):. PubMed ID: 33087515
[TBL] [Abstract][Full Text] [Related]
4. IMP-68, a Novel IMP-Type Metallo-β-Lactamase in Imipenem-Susceptible Klebsiella pneumoniae.
Kubota H; Suzuki Y; Okuno R; Uchitani Y; Ariyoshi T; Takemura N; Mihara F; Mezaki K; Ohmagari N; Matsui M; Suzuki S; Sekizuka T; Kuroda M; Yokoyama K; Sadamasu K
mSphere; 2019 Oct; 4(5):. PubMed ID: 31666316
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and antimicrobial susceptibility profiles of Enterobacterales causing bloodstream infections before and during COVID-19 pandemic: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) in Taiwan, 2018-2021.
Lee YL; Liu CE; Tang HJ; Huang YT; Chen YS; Hsueh PR;
J Microbiol Immunol Infect; 2024 Jun; 57(3):446-456. PubMed ID: 38632023
[TBL] [Abstract][Full Text] [Related]
6. Confronting Ceftolozane-Tazobactam Susceptibility in Multidrug-Resistant Enterobacterales Isolates and Whole-Genome Sequencing Results (STEP Study).
Hernández-García M; García-Fernández S; García-Castillo M; Melo-Cristino J; Pinto MF; Gonçalves E; Alves V; Costa E; Ramalheira E; Sancho L; Diogo J; Ferreira R; Silva T; Chaves C; Pássaro L; Paixão L; Romano J; Cantón R;
Int J Antimicrob Agents; 2021 Feb; 57(2):106259. PubMed ID: 33310115
[TBL] [Abstract][Full Text] [Related]
7. First report in China of Enterobacteriaceae clinical isolates coharboring blaNDM-1 and blaIMP-4 drug resistance genes.
Chen Z; Wang Y; Tian L; Zhu X; Li L; Zhang B; Yan S; Sun Z
Microb Drug Resist; 2015 Apr; 21(2):167-70. PubMed ID: 25389598
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.
Hagihara M; Kato H; Sugano T; Okade H; Sato N; Shibata Y; Sakanashi D; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Mikamo H
Int J Antimicrob Agents; 2021 May; 57(5):106330. PubMed ID: 33789129
[TBL] [Abstract][Full Text] [Related]
9. Impact of specific inhibitors on metallo-β-carbapenemases detected in Escherichia coli and Klebsiella pneumoniae isolates.
Abbas HA; Kadry AA; Shaker GH; Goda RM
Microb Pathog; 2019 Jul; 132():266-274. PubMed ID: 31096002
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey].
Çakar A; Akyön Y; Gür D; Karatuna O; Öğünç D; Özhak Baysan B; Çöplü N; Çağatay M; Kılıç A; Baysallar M; Bakıcı Z; Çelik C; Gülay Z; Aydemir Ş; Tünger A; Kılıç H; Erçal BD; Aşçı Toraman Z; Zer Y; Büyüktaş A; Ay S; Aktaş Z; Kayacan Ç; Bayramoğlu G; Aydın F; Dündar D; Hasdemir U; Ayaş R; Yanık K; Günaydın M; Güdücüoğlu H; Parlak M
Mikrobiyol Bul; 2016 Jan; 50(1):21-33. PubMed ID: 27058326
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genomic characteristics of IMP-producing
Suzuki D; Sakurai A; Wakuda M; Suzuki M; Doi Y
Antimicrob Agents Chemother; 2024 May; 68(5):e0167223. PubMed ID: 38517188
[TBL] [Abstract][Full Text] [Related]
12. The importance of meropenem resistance, rather than imipenem resistance, in defining carbapenem-resistant Enterobacterales for public health surveillance: an analysis of national population-based surveillance.
Ikenoue C; Matsui M; Inamine Y; Yoneoka D; Sugai M; Suzuki S;
BMC Infect Dis; 2024 Feb; 24(1):209. PubMed ID: 38360618
[TBL] [Abstract][Full Text] [Related]
13. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
[TBL] [Abstract][Full Text] [Related]
14. Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals--results from Czech Part of European Survey on Carbapenemase--Producing Enterobacteriaceae (EuSCAPE).
Hrabák J; Študentová V; Jakubů V; Adámková V; Dvořáková L; Balejova M; Bergerová T; Chmelařová E; Ježek P; Kabelíková P; Kolář M; Paterová P; Tejkalová R; Papagiannitsis C; Žemličková H
Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):87-91. PubMed ID: 26099612
[TBL] [Abstract][Full Text] [Related]
15. Trends and molecular characteristics of carbapenemase-producing Enterobacteriaceae in Japanese hospital from 2006 to 2015.
Eda R; Nakamura M; Takayama Y; Maehana S; Nakano R; Yano H; Kitasato H
J Infect Chemother; 2020 Jul; 26(7):667-671. PubMed ID: 32222331
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant Klebsiella pneumoniae in hospital-acquired infections: Concomitant analysis of antimicrobial resistant strains.
Khairy RMM; Mahmoud MS; Shady RR; Esmail MAM
Int J Clin Pract; 2020 Apr; 74(4):e13463. PubMed ID: 31830351
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.
Alsharapy SA; Gharout-Sait A; Muggeo A; Guillard T; Cholley P; Brasme L; Bertrand X; Moghram GS; Touati A; De Champs C
Microb Drug Resist; 2020 Mar; 26(3):211-217. PubMed ID: 31397629
[No Abstract] [Full Text] [Related]
18. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
19. Modified Hodge test using Mueller-Hinton agar supplemented with cloxacillin improves screening for carbapenemase-producing clinical isolates of Enterobacteriaceae.
Takayama Y; Adachi Y; Nihonyanagi S; Okamoto R
J Med Microbiol; 2015 Jul; 64(7):774-777. PubMed ID: 25934552
[TBL] [Abstract][Full Text] [Related]
20. Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance.
van der Zwaluw K; Witteveen S; Wielders L; van Santen M; Landman F; de Haan A; Schouls LM; Bosch T;
Clin Microbiol Infect; 2020 Oct; 26(10):1412.e7-1412.e12. PubMed ID: 32006688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
